PDB Short entry for 5U44 HEADER PROTEIN BINDING/ACTIVATOR 03-DEC-16 5U44 TITLE HUMAN PPARDELTA LIGAND-BINDING DOMAIN IN COMPLEXED WITH SPECIFIC TITLE 2 AGONIST 13 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-DELTA,NUCI,NUCLEAR HORMONE RECEPTOR 1,NUC1,NUCLEAR COMPND 6 RECEPTOR SUBFAMILY 1 GROUP C MEMBER 2,PEROXISOME PROLIFERATOR- COMPND 7 ACTIVATED RECEPTOR BETA,PPAR-BETA; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARD, NR1C2, PPARB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS PPARDELTA, LIGAND-BINDING DOMAIN, AGONIST, PROTEIN BINDING-ACTIVATOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.-C.WU,T.J.BAIGA,M.DOWNES,J.J.LA CLAIR,A.R.ATKINS,S.B.RICHARD, AUTHOR 2 T.A.STOCKLEY-NOEL,M.E.BOWMAN,R.M.EVANS,J.P.NOEL REVDAT 6 04-OCT-23 5U44 1 HETSYN REVDAT 5 29-JUL-20 5U44 1 COMPND REMARK HETNAM SITE REVDAT 5 2 1 ATOM REVDAT 4 22-NOV-17 5U44 1 REMARK REVDAT 3 05-APR-17 5U44 1 JRNL REVDAT 2 29-MAR-17 5U44 1 JRNL REVDAT 1 22-MAR-17 5U44 0 JRNL AUTH C.C.WU,T.J.BAIGA,M.DOWNES,J.J.LA CLAIR,A.R.ATKINS, JRNL AUTH 2 S.B.RICHARD,W.FAN,T.A.STOCKLEY-NOEL,M.E.BOWMAN,J.P.NOEL, JRNL AUTH 3 R.M.EVANS JRNL TITL STRUCTURAL BASIS FOR SPECIFIC LIGATION OF THE PEROXISOME JRNL TITL 2 PROLIFERATOR-ACTIVATED RECEPTOR DELTA. JRNL REF PROC. NATL. ACAD. SCI. V. 114 E2563 2017 JRNL REF 2 U.S.A. JRNL REFN ESSN 1091-6490 JRNL PMID 28320959 JRNL DOI 10.1073/PNAS.1621513114 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 95.32 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 80.8 REMARK 3 NUMBER OF REFLECTIONS : 31153 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1564 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 95.4175 - 4.7816 1.00 3370 196 0.1756 0.2068 REMARK 3 2 4.7816 - 3.7952 1.00 3364 168 0.1443 0.2094 REMARK 3 3 3.7952 - 3.3155 1.00 3315 161 0.1799 0.2278 REMARK 3 4 3.3155 - 3.0123 1.00 3310 185 0.2134 0.2792 REMARK 3 5 3.0123 - 2.7964 1.00 3338 173 0.2310 0.3204 REMARK 3 6 2.7964 - 2.6315 0.96 3177 172 0.2511 0.2908 REMARK 3 7 2.6315 - 2.4997 0.93 3083 155 0.2718 0.3467 REMARK 3 8 2.4997 - 2.3909 0.55 1833 103 0.2701 0.3181 REMARK 3 9 2.3909 - 2.2988 0.51 1674 86 0.2604 0.3198 REMARK 3 10 2.2988 - 2.2195 0.49 1603 92 0.2869 0.3252 REMARK 3 11 2.2195 - 2.1501 0.46 1522 73 0.3006 0.3275 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.430 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4389 REMARK 3 ANGLE : 0.532 5926 REMARK 3 CHIRALITY : 0.035 676 REMARK 3 PLANARITY : 0.002 741 REMARK 3 DIHEDRAL : 10.980 2638 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ( CHAIN A AND ( RESID 174:438 OR RESID 501:504 ) ) REMARK 3 ORIGIN FOR THE GROUP (A): 39.8551 -0.8193 124.4218 REMARK 3 T TENSOR REMARK 3 T11: 0.2782 T22: 0.1983 REMARK 3 T33: 0.2104 T12: 0.0157 REMARK 3 T13: 0.0429 T23: 0.0261 REMARK 3 L TENSOR REMARK 3 L11: 1.4507 L22: 1.0366 REMARK 3 L33: 4.5557 L12: -0.1474 REMARK 3 L13: -0.0363 L23: 0.5215 REMARK 3 S TENSOR REMARK 3 S11: 0.0266 S12: 0.0014 S13: 0.0523 REMARK 3 S21: 0.0421 S22: 0.0115 S23: -0.0438 REMARK 3 S31: -0.0509 S32: -0.2165 S33: -0.0354 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: ( CHAIN A AND RESID 505:505 ) OR ( CHAIN B AND ( REMARK 3 RESID 172:438 OR RESID 501:502 ) ) REMARK 3 ORIGIN FOR THE GROUP (A): 40.8477 -39.8648 113.1886 REMARK 3 T TENSOR REMARK 3 T11: 0.2013 T22: 0.1750 REMARK 3 T33: 0.2009 T12: -0.0218 REMARK 3 T13: 0.0362 T23: -0.0001 REMARK 3 L TENSOR REMARK 3 L11: 2.0167 L22: 1.3972 REMARK 3 L33: 3.2513 L12: 0.1765 REMARK 3 L13: -0.8279 L23: 0.0273 REMARK 3 S TENSOR REMARK 3 S11: -0.0532 S12: 0.1116 S13: -0.0810 REMARK 3 S21: 0.0378 S22: -0.0510 S23: 0.0837 REMARK 3 S31: 0.1075 S32: -0.3006 S33: 0.0601 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5U44 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1000225275. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 - 8.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31224 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 95.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 44.8 REMARK 200 DATA REDUNDANCY IN SHELL : 1.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1GWZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BIS-TRIS PROPANE, POTASSIUM CHLORIDE, REMARK 280 PEG 8000, 1,2-PROPANDIOL, EDTA, DTT, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.70500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 170 REMARK 465 GLN A 171 REMARK 465 VAL A 172 REMARK 465 ALA A 173 REMARK 465 LEU A 226 REMARK 465 VAL A 227 REMARK 465 TRP A 228 REMARK 465 LYS A 229 REMARK 465 GLN A 230 REMARK 465 LEU A 231 REMARK 465 VAL A 232 REMARK 465 ASN A 233 REMARK 465 ASP A 439 REMARK 465 MET A 440 REMARK 465 TYR A 441 REMARK 465 PRO B 170 REMARK 465 GLN B 171 REMARK 465 VAL B 227 REMARK 465 TRP B 228 REMARK 465 LYS B 229 REMARK 465 GLN B 230 REMARK 465 LEU B 231 REMARK 465 VAL B 232 REMARK 465 ASN B 233 REMARK 465 ASP B 439 REMARK 465 MET B 440 REMARK 465 TYR B 441 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH22 ARG A 198 O VAL A 298 1.47 REMARK 500 HH22 ARG B 198 O VAL B 298 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 236 172.69 -59.28 REMARK 500 GLU A 240 -179.03 -170.78 REMARK 500 ASN A 366 73.77 -107.55 REMARK 500 HIS A 389 73.37 -119.88 REMARK 500 PRO B 236 174.30 -58.02 REMARK 500 HIS B 389 71.86 -116.35 REMARK 500 GLU B 424 73.95 -117.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5U3Q RELATED DB: PDB REMARK 900 RELATED ID: 5U3R RELATED DB: PDB REMARK 900 RELATED ID: 5U3S RELATED DB: PDB REMARK 900 RELATED ID: 5U3T RELATED DB: PDB REMARK 900 RELATED ID: 5U3U RELATED DB: PDB REMARK 900 RELATED ID: 5U3V RELATED DB: PDB REMARK 900 RELATED ID: 5U3W RELATED DB: PDB REMARK 900 RELATED ID: 5U3X RELATED DB: PDB REMARK 900 RELATED ID: 5U3Y RELATED DB: PDB REMARK 900 RELATED ID: 5U3Z RELATED DB: PDB REMARK 900 RELATED ID: 5U40 RELATED DB: PDB REMARK 900 RELATED ID: 5U41 RELATED DB: PDB REMARK 900 RELATED ID: 5U42 RELATED DB: PDB REMARK 900 RELATED ID: 5U43 RELATED DB: PDB REMARK 900 RELATED ID: 5U45 RELATED DB: PDB REMARK 900 RELATED ID: 5U46 RELATED DB: PDB DBREF 5U44 A 170 441 UNP Q03181 PPARD_HUMAN 131 402 DBREF 5U44 B 170 441 UNP Q03181 PPARD_HUMAN 131 402 SEQRES 1 A 272 PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE SEQRES 2 A 272 TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS SEQRES 3 A 272 LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR SEQRES 4 A 272 ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN SEQRES 5 A 272 ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY SEQRES 6 A 272 LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR SEQRES 7 A 272 ARG CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU SEQRES 8 A 272 THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU SEQRES 9 A 272 PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 10 A 272 HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN SEQRES 11 A 272 LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL SEQRES 12 A 272 THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER SEQRES 13 A 272 ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 14 A 272 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE SEQRES 15 A 272 ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU SEQRES 16 A 272 MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE SEQRES 17 A 272 LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO SEQRES 18 A 272 ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET SEQRES 19 A 272 ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET SEQRES 20 A 272 MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU SEQRES 21 A 272 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET TYR SEQRES 1 B 272 PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE SEQRES 2 B 272 TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS SEQRES 3 B 272 LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR SEQRES 4 B 272 ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN SEQRES 5 B 272 ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY SEQRES 6 B 272 LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR SEQRES 7 B 272 ARG CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU SEQRES 8 B 272 THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU SEQRES 9 B 272 PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 10 B 272 HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN SEQRES 11 B 272 LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL SEQRES 12 B 272 THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER SEQRES 13 B 272 ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 14 B 272 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE SEQRES 15 B 272 ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU SEQRES 16 B 272 MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE SEQRES 17 B 272 LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO SEQRES 18 B 272 ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET SEQRES 19 B 272 ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET SEQRES 20 B 272 MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU SEQRES 21 B 272 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET TYR HET B7G A 501 45 HET PGO A 502 13 HET PGO A 503 13 HET 7SV A 504 64 HET B7G A 505 45 HET PGO B 501 13 HET 7SV B 502 64 HETNAM B7G HEPTYL BETA-D-GLUCOPYRANOSIDE HETNAM PGO S-1,2-PROPANEDIOL HETNAM 7SV 6-(2-{[CYCLOPROPYL(2'-FLUORO[1,1'-BIPHENYL]-4- HETNAM 2 7SV CARBONYL)AMINO]METHYL}PHENOXY)HEXANOIC ACID HETSYN B7G HEPTYL-BETA-D-GLUCOPYRANOSIDE; HEPTYL BETA-D-GLUCOSIDE; HETSYN 2 B7G HEPTYL D-GLUCOSIDE; HEPTYL GLUCOSIDE FORMUL 3 B7G 2(C13 H26 O6) FORMUL 4 PGO 3(C3 H8 O2) FORMUL 6 7SV 2(C29 H30 F N O4) FORMUL 10 HOH *93(H2 O) HELIX 1 AA1 ASP A 174 PHE A 190 1 17 HELIX 2 AA2 THR A 193 GLY A 203 1 11 HELIX 3 AA3 ASP A 215 GLY A 225 1 11 HELIX 4 AA4 GLU A 240 SER A 266 1 27 HELIX 5 AA5 ILE A 267 SER A 272 1 6 HELIX 6 AA6 PHE A 274 ALA A 295 1 22 HELIX 7 AA7 ARG A 314 LEU A 320 1 7 HELIX 8 AA8 ILE A 328 ALA A 340 1 13 HELIX 9 AA9 ASP A 344 LEU A 357 1 14 HELIX 10 AB1 ASN A 366 HIS A 389 1 24 HELIX 11 AB2 TYR A 394 GLU A 424 1 31 HELIX 12 AB3 HIS A 430 TYR A 437 1 8 HELIX 13 AB4 ASP B 174 PHE B 190 1 17 HELIX 14 AB5 THR B 193 THR B 202 1 10 HELIX 15 AB6 ASP B 215 LEU B 226 1 12 HELIX 16 AB7 GLU B 240 SER B 266 1 27 HELIX 17 AB8 ILE B 267 SER B 272 1 6 HELIX 18 AB9 PHE B 274 ALA B 295 1 22 HELIX 19 AC1 ARG B 314 SER B 319 1 6 HELIX 20 AC2 PRO B 323 ALA B 340 1 18 HELIX 21 AC3 ASP B 344 LEU B 357 1 14 HELIX 22 AC4 ASN B 366 HIS B 389 1 24 HELIX 23 AC5 TYR B 394 GLU B 424 1 31 HELIX 24 AC6 HIS B 430 TYR B 437 1 8 SHEET 1 AA1 4 PHE A 211 ILE A 213 0 SHEET 2 AA1 4 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213 SHEET 3 AA1 4 GLY A 302 VAL A 305 -1 N VAL A 305 O GLY A 310 SHEET 4 AA1 4 VAL A 298 ASN A 299 -1 N ASN A 299 O GLY A 302 SHEET 1 AA2 4 PHE B 211 ILE B 213 0 SHEET 2 AA2 4 GLY B 310 THR B 313 1 O PHE B 311 N ILE B 213 SHEET 3 AA2 4 GLY B 302 VAL B 305 -1 N VAL B 305 O GLY B 310 SHEET 4 AA2 4 VAL B 298 ASN B 299 -1 N ASN B 299 O GLY B 302 CISPEP 1 LYS A 322 PRO A 323 0 2.24 CISPEP 2 LYS B 322 PRO B 323 0 3.74 CRYST1 39.570 95.410 96.180 90.00 97.65 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025272 0.000000 0.003394 0.00000 SCALE2 0.000000 0.010481 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010491 0.00000